Accession Number : ADA320184

Title :   Drug Development and Conservation of Biodiversity in West and Central Africa.

Descriptive Note : Annual rept. 31 Aug 95-30 Aug 96,

Corporate Author : SMITHSONIAN INSTITUTION WASHINGTON DC

Personal Author(s) : Losos, Elizabeth C.

PDF Url : ADA320184

Report Date : SEP 1996

Pagination or Media Count : 9

Abstract : Due to various delays, AP1 has had a belated start compared to the other APs. However, substantial gains were made in the planning for two of the three AP1 components and in training Cameroonian and Nigerian partners in an intensive biodiversity monitoring course in the US. With planning and training underway, it is expected that, during the fourth quarter (when the dry season begins), two of the AP1 programs will begin active research and training in Cameroon.

Descriptors :   *BACTERIA, *DRUGS, *INVERTEBRATES, *MICROORGANISMS, AMPHIBIANS, MAMMALS, MOISTURE CONTENT, FRESH WATER, LOW LEVEL, VEGETATION, SEASONS, WEST AFRICA, REPTILES.

Subject Categories : Biology
      Anatomy and Physiology
      Pharmacology

Distribution Statement : APPROVED FOR PUBLIC RELEASE